Clinical Trial Update: hCT-MSC in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for hCT-MSC in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• hCT-MSC (human cord tissue-derived mesenchymal stem cells)

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Autism, Autism Spectrum Disorder | Phase 2 | Status: COMPLETED